Selected References: Askew J, 2007. Zolpidem addiction in pregnant woman with a history of second trimester bleeding. Pharmacotherapy, 27(2):306-308. Huitfeldt A, et al. 2020. Associations of maternal use of benzodiazepines or benzodiazepine-like hypnotics during pregnancy with immediate pregnancy outcomes in Norway. JAMA Netw Open, 3(6):e205860. Fung K, et al. 2026. Z-drug use in the first trimester of pregnancy and risk of congenital malformations. JAMA Psychiatry,83(2): …
The Baby Blog
About Our Baby Blog
Every person wants to know what’s best for their baby, especially when it comes to knowing how to minimize exposure risks. Our relatable stories are packed with practical information from our rotating staff of MotherToBaby expert bloggers. Whatever topic you’re looking for, our blogs will provide you a great foundation to learn more.
Metformin
Selected References: Abolhassani N, et al. 2023. Major malformations risk following early pregnancy exposure to metformin: a systematic review and meta-analysis. BMJ Open Diab Res Care: 11(1):e002919. Bhorat I, et al. 2019. Assessment of the fetal myocardial performance index in well‐controlled gestational diabetics & to determine whether it is predictive of adverse perinatal outcome. Pediatr Cardiol. 40(7):1460–1467. Boggess KA, et al. 2023. Metformin plus insulin for …
Hantaviruses
Selected References: Bellomo C, et al. 2019. A newborn infected by Andes virus suggests novel routes of hantavirus transmission: a case report. Clin Microbiol Infect; 26(1):130-131. Centers for Disease Control and Prevention. 2024. About Hantavirus. Available at: https://www.cdc.gov/hantavirus/about/index.html. [Accessed May 7, 2026]. Centers for Disease Control and Prevention. 2026. Clinician Brief: Hantavirus Pulmonary Syndrome (HPS). Available at: …
Natalizumab
Selected References: Andersen JB, et al. 2023. Pregnancy outcomes after early fetal exposure to injectable first-line treatments, dimethyl fumarate, or natalizumab in Danish women with multiple sclerosis. European journal of neurology; 30(1), 162–171. Bast N, et al. 2024. Impact of disease-modifying therapies on pregnancy outcomes in multiple sclerosis: a prospective cohort study from the German multiple sclerosis and pregnancy registry. Lancet Reg Health Eur; 48: 101137. …
Insulin Glargine
Selected References: Biocon Biologics Inc. 2025. Semglee Product Label. National Institute of Health DailyMed database. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?. Accessed May 2025. Bruttomesso D, et al. 2011. Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI). Diabetes Metab; 37(5):426-431. …
